Albemarle Corporation (ALB) Analyst Forecast
Revenue and earnings estimates published by analysts covering Albemarle Corporation (ALB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Albemarle Corporation, analysts forecast revenue rising from $5060.35T in 2025 to $7397.00T in 2030; the average estimate for 2030 earnings per share is $13.90; with published estimates ranging from $12.11 to $16.61; 16 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD millions)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Albemarle Corporation (ALB) forecast — frequently asked questions
What is the analyst price target for Albemarle Corporation?
Analysts covering Albemarle Corporation (ALB) have a consensus price target of $167.09, 77.4% above the current price of $94.21. Published targets range from $109.00 to $250.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for Albemarle Corporation's earnings?
The average analyst estimate for Albemarle Corporation (ALB) earnings per share in 2030 is 13.90, with individual estimates between 12.11 and 16.61.
How much revenue is Albemarle Corporation expected to make?
Analysts forecast Albemarle Corporation (ALB) revenue of $7397.00T in 2030, based on 12 published estimates.
How many analysts cover ALB?
16 analysts contribute estimates for Albemarle Corporation (ALB). Thin coverage makes an average less reliable.
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.